Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-745-1
CAS number: 6701-13-9
No reproduction data is available on 1,10 decanediyl bis
However, a Combined Repeated Dose Toxicity Study with the
Reproduction / Developmental Toxicity Screening Test according to OECD
Guideline 422 is available on an analogue substance of 1,10 decanediyl
bis methacrylate,1,4-Butanediol dimethacrylate.
On the basis of the results obtained in this study, the NOAEL (No
Observed Adverse Effect Level) for both systemic and reproduction
toxicity is considered to be 300 mg/kg/day for males and females.
In a Combined Repeated Dose Toxicity Study with the Reproduction /
Developmental Toxicity Screening Test according to OECD Guideline 422
(22 March 1996) 1,4-Butanediol dimethacrylate was administered to 10
Hsd: Sprague Dawley SD rats/sex/dose orally by gavage at dose levels of
0 (control), 100, 300 and 1000 mg/kg bw/d. The treatment schedule
included 2 weeks before pairing, during pairing, post coitum and post
partum periods up to day 3 post partum. Animals were administered for
approximately 5 and 8 weeks for males and females, respectively.
No mortality occurred in the study. A total of 8 females were
found not pregnant at necropsy: one each in the control and low dose
groups and 6 in the high dose group.
The number of females with live pups on Day 4 post-partum were: 9 in the
control group, 9 in the low dose group, 10 in the mid-dose group and 4
in the high dose group.
No clinical signs of toxicological significance were reported.
Body weight and body weight gain were lower in the high dose group
compared to controls throughout the study.
Food consumption was reduced in the high dose group compared to
controls.No relevant differences were noted in all parameters
investigated between control and treated groups.
No changes of toxicological significance were found.
The main relevant change was an increased value of bile acids in treated
groups compared tocontrols with a clear dose-relation in males.
No changes were recorded in urinalysis.
Measurements of oestrus cycle, pre-coital intervals and copulatory index
did not show differences between treated and control groups. On the
contrary, fertility index was markedly reduced in the high dose group
(40% compared to 90% of the control group).
No significant differences were observed in the number of implantation,
corpora lutea, total litter size, pre-implantation loss, pre-birth loss
and gestation length between control and treated groups.
Reduced litter and mean pup weights were found in the high dose group
compared to controls. The percentage of cumulative pup loss on Day 4
post partum starting from the total litter size at birth, was increased
in the high dose group.
No differences were found in sex ratio between the groups.
Small pups were generally observed in all groups including the control
group. Cold to touch and apparently no food intake were the signs noted
in pups of the treated groups only.
No relevant differences were recorded in decedent pups between the
No abnormalities were observed in pups sacrificed at term.
Terminal body weight was lower in the high dose group compared to
controls and this difference was statistically significant in females.
Statistically significant higher kidneys weight was observed in high
dose males and females
compared to controls. In addition, thymus weight was significantly
decreased in high dose males.
No treatment-related changes were noted at macroscopic examination.
Treatment-related findings at microscpopic observations were limited to
the high dosed animals and were seen in the stomach of both sexes and in
the liver of the females only.Stomach (non-glandular)
The treatment-related change seen in the high dosed animals (1/10 and
5/10, respectively in males and females), consisted of mild diffused
hyperplasia of the squamous epithelium in the non-glandural stomach,
which was associated with mild thickening (i.e., hyperkerathosis) of the
keratin layer. This change was not associated with any indication of
In 3/10 high dose animals (females), minimal degree of multifocal
perilobular hepatocytic vacuolaiton, which is suggested to be consistent
with fatty change, was noted. The vacuoles were of mixed type (i.e.,
micro- and macrovesicular) and no presence of inflammation
and/ornecrosis was noted.
Evaluation of the spermatogenic cycle did not show differences between
the groups. Regular layering in the germinal epithelium was noted.
On the basis of the results obtained in the study, the NOAEL (No
Observed Adverse Effect Level) for both general toxicity and
reproduction/developmental toxicity could be considered 300 mg/kg/day
for males and females.The pronounced reduction of body weight
gain of the premating animals indicates that the reduced reproduction
success is likely a secondary effect of general systemic toxicity
resulting in a poor condition of the parent females.
Based on the available data, no classification is required for
reproduction toxicity according to the Regulation EC No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again